Chalmers spin-off Amferia on Brilliant Minds 2019 - Chalmers Ventures

Chalmers spin-off Amferia on Brilliant Minds 2019

Amferia AB, a Chalmers Ventures portfolio company, develops innovative antibacterial technologies to prevent dangerous wound infections, including those arising from the the antibiotic resistant bacteria.

The company was recently invited to present their innovation and vision at the annual Brilliant Minds meeting in Stockholm. Brilliant Minds Foundation was founded to support creative individuals with transformative ideas within entrepreneurship, technology, fashion, health, finance and education. Among the esteemed invited speakers were former US president Barack Obama, Former Secretary of State, John Kerry and Climate Activist Greta Thunberg along with some of the greatest entrepreneurs of our time. Amferia’s CEO, Anand Kumar Rajasekharan had the honour of being one among the invited speakers who presented Amferia at the conference.